Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
SCG Cell Therapy's Phase 1 trial of SCG101, an autologous HBV-specific TCR-T cell therapy, demonstrated sustained clearance of hepatitis B surface antigen in 94% of heavily pre-treated HBV-related liver cancer patients.
SCG101, an autologous HBV-specific TCR-T cell therapy, demonstrated substantial antiviral activity in patients with advanced HBV-related hepatocellular carcinoma.